Dwarfism: Clinical Trials

6 trials for Dwarfism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Unknown 6

Follow Dwarfism: new trials by email Literature Review of Dwarfism trials Research Report on Dwarfism

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
PEG-somatropin - Growth Hormone Deficiency
Phase 4UnknownChangchun GeneScience Pharmaceutical Co., Ltd.6002015-01-012017-06-16
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
PEG-somatropin - Growth Hormone Deficiency
Phase 4UnknownChangchun GeneScience Pharmaceutical Co., Ltd.9002015-01-012017-08-15
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
PEG-somatropin - Growth Hormone Deficiency
Phase 4UnknownChangchun GeneScience Pharmaceutical Co., Ltd.6002014-12-012017-06-16
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
PEG-somatropin - Dwarfism, Pituitary
Phase 4UnknownChangchun GeneScience Pharmaceutical Co., Ltd.9002014-11-012014-12-11
Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
PEG-somatropin - Growth Hormone Deficiency
Phase 4UnknownChangchun GeneScience Pharmaceutical Co., Ltd.9002014-11-012017-06-14
Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
Growth Hormone - Chronic Myelogenous Leukemia, Short Stature
Phase 4UnknownPost Graduate Institute of Medical Education and Research, Chandigarh202013-01-012013-07-17

Narrower conditions

Dwarfism, Pituitary (5)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)

Broader conditions

Bone Diseases (6)  ·  Bone Diseases, Developmental (6)  ·  Endocrine System Diseases (6)  ·  Musculoskeletal Diseases (6)  ·  Bone Diseases, Endocrine (5)  ·  Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Hypopituitarism (5)  ·  Hypothalamic Diseases (5)  ·  Nervous System Diseases (5)  ·  Pituitary Diseases (5)  ·  Bone Marrow Diseases (1)  ·  Chronic Disease (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Growth Hormone (1)

Sponsors

Changchun GeneScience Pharmaceutical Co., Ltd. (5)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)

Countries

China (5)  ·  India (1)

Top investigators

Chunxiu Gong (1)  ·  Feihong Luo, Doctor (1)  ·  Junfen Fu, Ph.D (1)  ·  Junfen Fu, PhD (1)

Results publications

PMID 34899612, PMID 35945517, PMID 36034802